An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells

Zhou, G; Da Won Bae, S; Nguyen, R; Huo, X; Han, S; Zhang, Z; Hebbard, L; Duan, Wei; Eslam, M; Liddle, C; Yuen, L; Lam, V; Qiao, L; George, J

File(s) under permanent embargo

An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells

journal contribution

posted on 2021-03-01, 00:00 authored by G Zhou, S Da Won Bae, R Nguyen, X Huo, S Han, Z Zhang, L Hebbard, Wei DuanWei Duan, M Eslam, C Liddle, L Yuen, V Lam, L Qiao, J George

An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells

History

Journal

Cancer Letters

Volume

501

Pagination

124-132

Location

Ireland

Publisher DOI

https://doi.org/10.1016/j.canlet.2020.12.022

ISSN

0304-3835

eISSN

1872-7980

Language

English

Author URL

https://www.ncbi.nlm.nih.gov/pubmed/33352247

Publication classification

C1 Refereed article in a scholarly journal

Publisher

ELSEVIER IRELAND LTD

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Oncology Hepatocellular carcinoma (HCC)Aptamer Cancer stem-like cells CD133 Therapeutic targeting VASCULOGENIC MIMICRY TUMOR PENETRATION SURVIVAL ANTIBODY CONTRIBUTES EXPRESSION RESISTANCE AUTOPHAGY 3214 Pharmacology and pharmaceutical sciences

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

File(s) under permanent embargo

An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells

History

Journal

Volume

Pagination

Location

Publisher DOI

ISSN

eISSN

Language

Author URL

Publication classification

Publisher

Usage metrics

Categories

Keywords

Licence

Exports